Health Catalyst, Inc.
HCAT
$4.18
$0.0651.58%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -40.38% | -8.95% | 34.35% | 32.08% | -37.58% |
Total Depreciation and Amortization | 3.78% | -10.46% | 2.86% | -0.96% | 1.41% |
Total Amortization of Deferred Charges | -3.69% | 42.50% | -3.56% | 12.10% | 0.04% |
Total Other Non-Cash Items | 25.99% | -24.01% | -33.61% | 15.25% | 0.54% |
Change in Net Operating Assets | -238.86% | 145.08% | -194.99% | 148.07% | -622.59% |
Cash from Operations | -156.81% | 285.11% | -84.30% | 153.92% | -711.27% |
Capital Expenditure | 41.42% | -143.10% | -39.42% | 18.43% | -71.14% |
Sale of Property, Plant, and Equipment | 0.00% | -25.00% | 33.33% | -70.00% | 0.00% |
Cash Acquisitions | 29.93% | -94.17% | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -295.05% | 159.75% | -79.61% | 102.60% | 268.11% |
Cash from Investing | -1,574.61% | 528.83% | -102.12% | 180.72% | 220.35% |
Total Debt Issued | -68.13% | -- | -- | -- | -- |
Total Debt Repaid | 51.55% | -- | -- | -- | -- |
Issuance of Common Stock | -47.68% | -4.15% | -19.12% | 118.48% | -62.02% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 128.27% | -- | -- | -- | -- |
Cash from Financing | -66.50% | 16,016.76% | -19.12% | 118.48% | -62.02% |
Foreign Exchange rate Adjustments | -215.66% | 4,250.00% | 89.47% | -155.88% | 326.67% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -162.23% | 23,982.29% | -99.45% | 741.17% | 154.57% |